Real-time enrollment status for this copd clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:18 PM UTC
| NCT Number | NCT06283966 |
| Recruiting Status | Recruiting |
| Condition | COPD |
| Phase | PHASE3 |
| Target Enrollment | 5,250 participants |
| Active Locations | 235 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 24, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06283966 is currently recruiting participants. This phase3 study for copd is actively seeking new participants at 235 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06283966 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 235 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06283966 was last updated 3 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.